C
China BCT Pharmacy Group Inc
OTC:CNBI
China BCT Pharmacy Group Inc
OTC:CNBI
Price:
0.0001
USD
Market Closed
Market Cap:
$3.8k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China BCT Pharmacy Group Inc
OTC:CNBI
|
CN |
|
N
|
Neuca SA
WSE:NEU
|
PL |
|
K
|
Kailuan Energy Chemical Co Ltd
SSE:600997
|
CN |
|
Best Buy Co Inc
NYSE:BBY
|
US |
|
Honda Motor Co Ltd
NYSE:HMC
|
JP |
|
S
|
Swadeshi Polytex Ltd
BSE:503816
|
IN |
|
P
|
Pagaya Technologies Ltd
NASDAQ:PGY
|
IL |
|
Crombie Real Estate Investment Trust
TSX:CRR.UN
|
CA |
Income Statement
Earnings Waterfall
China BCT Pharmacy Group Inc
China BCT Pharmacy Group Inc
Income Statement
China BCT Pharmacy Group Inc
China BCT Pharmacy Group Inc
Currency: USD
| Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
136
N/A
|
170
+25%
|
218
+28%
|
270
+24%
|
201
-26%
|
225
+12%
|
243
+8%
|
258
+6%
|
257
0%
|
270
+5%
|
266
-1%
|
254
-5%
|
242
-5%
|
237
-2%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
(101)
|
(25)
|
(60)
|
(99)
|
(152)
|
(172)
|
(186)
|
(198)
|
(196)
|
(205)
|
(204)
|
(198)
|
(193)
|
(194)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
36
N/A
|
9
-75%
|
22
+142%
|
35
+61%
|
49
+41%
|
54
+10%
|
57
+7%
|
60
+5%
|
62
+3%
|
65
+5%
|
62
-4%
|
56
-9%
|
49
-14%
|
43
-11%
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(0)
|
0
|
0
|
(9)
|
(112)
|
(114)
|
(118)
|
(13)
|
(16)
|
(18)
|
(18)
|
(20)
|
(19)
|
(19)
|
(20)
|
(19)
|
(20)
|
|
| Selling, General & Administrative |
(0)
|
0
|
0
|
(8)
|
(11)
|
(14)
|
(17)
|
(13)
|
(16)
|
(18)
|
(18)
|
(20)
|
(19)
|
(19)
|
(20)
|
(18)
|
(20)
|
|
| Research & Development |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
(101)
|
(100)
|
(100)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
0
N/A
|
0
N/A
|
27
N/A
|
33
+23%
|
43
+31%
|
53
+22%
|
35
-33%
|
38
+7%
|
39
+3%
|
42
+8%
|
42
+0%
|
46
+8%
|
43
-7%
|
36
-16%
|
29
-18%
|
23
-21%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
1
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(0)
N/A
|
0
N/A
|
0
N/A
|
26
N/A
|
31
+22%
|
41
+31%
|
50
+23%
|
35
-31%
|
38
+8%
|
40
+6%
|
43
+8%
|
42
-2%
|
45
+8%
|
42
-7%
|
35
-16%
|
29
-19%
|
22
-22%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
(6)
|
(8)
|
(10)
|
(13)
|
(9)
|
(10)
|
(11)
|
(12)
|
(11)
|
(12)
|
(11)
|
(9)
|
(7)
|
(6)
|
|
| Income from Continuing Operations |
(0)
|
0
|
0
|
19
|
24
|
31
|
38
|
26
|
28
|
29
|
32
|
31
|
34
|
32
|
26
|
21
|
17
|
|
| Net Income (Common) |
(0)
N/A
|
0
N/A
|
0
N/A
|
19
N/A
|
24
+22%
|
31
+30%
|
38
+22%
|
26
-32%
|
27
+6%
|
28
+1%
|
29
+5%
|
27
-6%
|
29
+7%
|
27
-8%
|
21
-20%
|
16
-25%
|
11
-28%
|
|
| EPS (Diluted) |
0
N/A
|
0
N/A
|
0
N/A
|
0.61
N/A
|
0.61
N/A
|
0.79
+30%
|
0.97
+23%
|
0.67
-31%
|
0.71
+6%
|
0.71
N/A
|
0.75
+6%
|
0.72
-4%
|
0.76
+6%
|
0.71
-7%
|
0.56
-21%
|
0.42
-25%
|
0.3
-29%
|
|
Switch to:
Switch to:
See Also
Discover More
